Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KLH-2109 in Uterine Fibroids and Menorrhagia
NCT07378098Phase 3Recruiting
- Sponsor
- JW Pharmaceutical Corporation
- Start
- Feb 2026
- Primary completion
- Mar 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of linzagolix in Uterine Fibroids (UF), Menorrhagia, sponsored by JW Pharmaceutical Corporation. Started Feb 2026; status: recruiting.
02
Drugs
linzagolix
03
Conditions
Uterine Fibroids (UF)Menorrhagia
Beyond the preview
Go deeper on NCT07378098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07378098.